| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9346088 | Ophthalmology | 2005 | 6 Pages |
Abstract
These data suggest that mycophenolate mofetil may be an effective corticosteroid-sparing agent in the treatment of inflammatory eye disease with a manageable side effect profile.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Jennifer E. MD, Douglas A. MD, MBA, Faqir A. (FRCS), Quan Dong MD, John H. MD, PhD, James P. MD,